Add to ORKGTo evaluate the impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with cancer. Longitudinal cohort study including women affected and unaffected with breast or ovar-ian cancer testing for a BRCA1/2 mutation. Data on well-being (anxiety, depression, cancer related distress, general health), treatment choice, and decision making about cancer prevention were collected at baseline (1 week after blood sampling; affec-ted n192, unaffected n176) and at follow-up (2 weeks after disclosure of a positive test result; affected n23, unaffected n66). Women affected and unaffected with breas
BACKGROUND: Genetic testing is increasing in patients newly diagnosed with cancer. This study invest...
PurposeBRCA1/BRCA2 predictive test negatives are proven non-carriers of a BRCA1/BRCA2 mutation that ...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...
To evaluate the impact of BRCA1/2 testing and disclosure of a positive test result on women affected...
To evaluate the impact of BRCA1/2 testing and disclosure of a positive test result on women affected...
Background: this prospective multi-centre UK study assesses the impact of predictive genetic testing...
BACKGROUND: BRCA1 and BRCA2 mutations are associated with a higher risk of breast and ovarian tumors...
International audienceThe effect of BRCA1/2 gene test result on anxiety, depression, cancer-related ...
This study sought to investigate the impact of BRCA1 and BRCA2 mutation searching on women previousl...
Germline BRCA1/2 testing of breast and ovarian cancer patients is growing rapidly as the result affe...
This prospective multicentre study assesses long-term impact of genetic testing for breast/ovarian c...
Item does not contain fulltextGenetic testing enables women at risk for hereditary breast and/or ova...
PurposeBRCA1/BRCA2 predictive test negatives are proven noncarriers of a BRCA1/BRCA2 mutation that i...
Background: Genetic testing is increasing in patients newly diagnosed with cancer. This study invest...
BACKGROUND: Over recent years genetic testing for germline mutations in BRCA1/BRCA2 has become more ...
BACKGROUND: Genetic testing is increasing in patients newly diagnosed with cancer. This study invest...
PurposeBRCA1/BRCA2 predictive test negatives are proven non-carriers of a BRCA1/BRCA2 mutation that ...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...
To evaluate the impact of BRCA1/2 testing and disclosure of a positive test result on women affected...
To evaluate the impact of BRCA1/2 testing and disclosure of a positive test result on women affected...
Background: this prospective multi-centre UK study assesses the impact of predictive genetic testing...
BACKGROUND: BRCA1 and BRCA2 mutations are associated with a higher risk of breast and ovarian tumors...
International audienceThe effect of BRCA1/2 gene test result on anxiety, depression, cancer-related ...
This study sought to investigate the impact of BRCA1 and BRCA2 mutation searching on women previousl...
Germline BRCA1/2 testing of breast and ovarian cancer patients is growing rapidly as the result affe...
This prospective multicentre study assesses long-term impact of genetic testing for breast/ovarian c...
Item does not contain fulltextGenetic testing enables women at risk for hereditary breast and/or ova...
PurposeBRCA1/BRCA2 predictive test negatives are proven noncarriers of a BRCA1/BRCA2 mutation that i...
Background: Genetic testing is increasing in patients newly diagnosed with cancer. This study invest...
BACKGROUND: Over recent years genetic testing for germline mutations in BRCA1/BRCA2 has become more ...
BACKGROUND: Genetic testing is increasing in patients newly diagnosed with cancer. This study invest...
PurposeBRCA1/BRCA2 predictive test negatives are proven non-carriers of a BRCA1/BRCA2 mutation that ...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...